Cargando…

Indeterminate nodules in osteosarcoma: what’s the follow-up?

BACKGROUND: Indeterminate pulmonary nodules in patients diagnosed with osteosarcoma present a challenge for accurate staging and prognosis. The aim of this study was to explore the significance of this finding. METHODS: A retrospective cohort study of 120 patients with osteosarcoma was performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, K M, Lee, L H, Beckingsale, T B, Gerrand, C H, Rankin, K S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846065/
https://www.ncbi.nlm.nih.gov/pubmed/29381684
http://dx.doi.org/10.1038/bjc.2017.453
_version_ 1783305531722563584
author Ghosh, K M
Lee, L H
Beckingsale, T B
Gerrand, C H
Rankin, K S
author_facet Ghosh, K M
Lee, L H
Beckingsale, T B
Gerrand, C H
Rankin, K S
author_sort Ghosh, K M
collection PubMed
description BACKGROUND: Indeterminate pulmonary nodules in patients diagnosed with osteosarcoma present a challenge for accurate staging and prognosis. The aim of this study was to explore the significance of this finding. METHODS: A retrospective cohort study of 120 patients with osteosarcoma was performed in the North East of England. Chest computed tomographies (CTs) at presentation were reviewed and the incidence of ‘indeterminate’ nodules recorded. Follow-up scans were reviewed and survival as well as prognostic features were analysed. RESULTS: 25% of our cohort presented with indeterminate nodules. Of these, 33% were subsequently confirmed as metastases, the majority within a year. Kaplan–Meier survival analysis showed that patients with indeterminate nodules fared better than those with frank metastatic disease, and similar to those who presented with a normal chest CT. We found no radiographic features that predicted survival. CONCLUSIONS: Indeterminate nodules remain a clinical and diagnostic dilemma. Close monitoring of patients is advised during the first year from presentation, and there is potential for indeterminate nodules to develop into frank metastases later than five years from presentation.
format Online
Article
Text
id pubmed-5846065
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58460652019-03-06 Indeterminate nodules in osteosarcoma: what’s the follow-up? Ghosh, K M Lee, L H Beckingsale, T B Gerrand, C H Rankin, K S Br J Cancer Clinical Study BACKGROUND: Indeterminate pulmonary nodules in patients diagnosed with osteosarcoma present a challenge for accurate staging and prognosis. The aim of this study was to explore the significance of this finding. METHODS: A retrospective cohort study of 120 patients with osteosarcoma was performed in the North East of England. Chest computed tomographies (CTs) at presentation were reviewed and the incidence of ‘indeterminate’ nodules recorded. Follow-up scans were reviewed and survival as well as prognostic features were analysed. RESULTS: 25% of our cohort presented with indeterminate nodules. Of these, 33% were subsequently confirmed as metastases, the majority within a year. Kaplan–Meier survival analysis showed that patients with indeterminate nodules fared better than those with frank metastatic disease, and similar to those who presented with a normal chest CT. We found no radiographic features that predicted survival. CONCLUSIONS: Indeterminate nodules remain a clinical and diagnostic dilemma. Close monitoring of patients is advised during the first year from presentation, and there is potential for indeterminate nodules to develop into frank metastases later than five years from presentation. Nature Publishing Group 2018-03-06 2018-01-30 /pmc/articles/PMC5846065/ /pubmed/29381684 http://dx.doi.org/10.1038/bjc.2017.453 Text en Copyright © 2018 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Clinical Study
Ghosh, K M
Lee, L H
Beckingsale, T B
Gerrand, C H
Rankin, K S
Indeterminate nodules in osteosarcoma: what’s the follow-up?
title Indeterminate nodules in osteosarcoma: what’s the follow-up?
title_full Indeterminate nodules in osteosarcoma: what’s the follow-up?
title_fullStr Indeterminate nodules in osteosarcoma: what’s the follow-up?
title_full_unstemmed Indeterminate nodules in osteosarcoma: what’s the follow-up?
title_short Indeterminate nodules in osteosarcoma: what’s the follow-up?
title_sort indeterminate nodules in osteosarcoma: what’s the follow-up?
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846065/
https://www.ncbi.nlm.nih.gov/pubmed/29381684
http://dx.doi.org/10.1038/bjc.2017.453
work_keys_str_mv AT ghoshkm indeterminatenodulesinosteosarcomawhatsthefollowup
AT leelh indeterminatenodulesinosteosarcomawhatsthefollowup
AT beckingsaletb indeterminatenodulesinosteosarcomawhatsthefollowup
AT gerrandch indeterminatenodulesinosteosarcomawhatsthefollowup
AT rankinks indeterminatenodulesinosteosarcomawhatsthefollowup